Cargando…

Carbon monoxide releasing molecule-2 (CORM-2) inhibits growth of multidrug-resistant uropathogenic Escherichia coli in biofilm and following host cell colonization

BACKGROUND: Increased resistance to antimicrobial agents is a characteristic of many bacteria growing in biofilms on for example indwelling urinary catheters or in intracellular bacterial reservoirs. Biofilm-related infections caused by multidrug-resistant bacteria, such as extended-spectrum β-lacta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahlberg Bang, Charlotte, Kruse, Robert, Johansson, Kjell, Persson, Katarina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828782/ https://www.ncbi.nlm.nih.gov/pubmed/27067266 http://dx.doi.org/10.1186/s12866-016-0678-7

Ejemplares similares

Global gene expression profiling and antibiotic susceptibility after repeated exposure to the carbon monoxide-releasing molecule-2 (CORM-2) in multidrug-resistant ESBL-producing uropathogenic Escherichia coli
por: Sahlberg Bang, Charlotte, et al.
Publicado: (2017)

The Carbon Monoxide Releasing Molecule CORM-2 Attenuates Pseudomonas aeruginosa Biofilm Formation
por: Murray, Thomas S., et al.
Publicado: (2012)

Transcriptional alterations in bladder epithelial cells in response to infection with different morphological states of uropathogenic Escherichia coli
por: Persson, Katarina, et al.
Publicado: (2022)

Carbon monoxide releasing molecule-2 (CORM-2)-liberated CO ameliorates acute pancreatitis
por: Liu, Yishu, et al.
Publicado: (2019)

The effect of carbon monoxide releasing molecule-2 (CORM-2) on healing of ischemic colon anastomosis in rats
por: KAYAPINAR, Ali Kemal, et al.
Publicado: (2021)

Carbon monoxide-Releasing Molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats
por: Wei, Yunwei, et al.
Publicado: (2010)

The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide
por: Bang, Charlotte Sahlberg, et al.
Publicado: (2014)

Bacteriophages with the Ability to Degrade Uropathogenic Escherichia Coli Biofilms
por: Chibeu, Andrew, et al.
Publicado: (2012)

Biofilm and fluoroquinolone resistance of canine Escherichia coli uropathogenic isolates
por: Oliveira, Manuela, et al.
Publicado: (2014)

Activation of the NLRP3 Inflammasome Pathway by Uropathogenic Escherichia coli Is Virulence Factor-Dependent and Influences Colonization of Bladder Epithelial Cells
por: Demirel, Isak, et al.
Publicado: (2018)

Activation of NLRP3 by uropathogenic Escherichia coli is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils
por: Demirel, Isak, et al.
Publicado: (2020)

Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm
por: Moazzezy, Neda, et al.
Publicado: (2020)

The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli
por: Lindblad, Anna, et al.
Publicado: (2022)

Anti-Biofilm Effect of Bacteriophages and Antibiotics against Uropathogenic Escherichia coli
por: Mukane, Laima, et al.
Publicado: (2022)

‘Carbon-Monoxide-Releasing Molecule-2 (CORM-2)’ Is a Misnomer: Ruthenium Toxicity, Not CO Release, Accounts for Its Antimicrobial Effects
por: Southam, Hannah M., et al.
Publicado: (2021)

High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran
por: Dehbanipour, Razieh, et al.
Publicado: (2016)

Multidrug resistance of uropathogenic Escherichia coli strains isolated from diabetic patients
por: Ionete, Oana Mariana, et al.
Publicado: (2014)

Molecular Factors and Mechanisms Driving Multidrug Resistance in Uropathogenic Escherichia coli—An Update
por: Rozwadowski, Marcin, et al.
Publicado: (2022)

Complete closed genome sequences of three multidrug-resistant uropathogenic Escherichia coli
por: Guragain, Manita, et al.
Publicado: (2023)

A Structurally-Tunable 3-Hydroxyflavone Motif for Visible Light-Induced Carbon Monoxide-Releasing Molecules (CORMs)**
por: Anderson, Stacey N, et al.
Publicado: (2015)

The Intercalation of CORM-2 with Pharmaceutical Clay Montmorillonite (MMT) Aids for Therapeutic Carbon Monoxide Release
por: Faizan, Muhammad, et al.
Publicado: (2019)

Alkaloids Modulate Motility, Biofilm Formation and Antibiotic Susceptibility of Uropathogenic Escherichia coli
por: Dusane, Devendra H., et al.
Publicado: (2014)

Inhibition and Inactivation of Uropathogenic Escherichia coli Biofilms on Urinary Catheters by Sodium Selenite
por: Narayanan, Amoolya, et al.
Publicado: (2018)

TosR-Mediated Regulation of Adhesins and Biofilm Formation in Uropathogenic Escherichia coli
por: Luterbach, Courtney L., et al.
Publicado: (2018)

Biofilm and hemagglutinin formation: a Hallmark for drug resistant uropathogenic Escherichia coli
por: Hagos, Dawit Gebreegziabiher, et al.
Publicado: (2019)

Respiratory Heterogeneity Shapes Biofilm Formation and Host Colonization in Uropathogenic Escherichia coli
por: Beebout, Connor J., et al.
Publicado: (2019)

The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms
por: Kalsy, Miriam, et al.
Publicado: (2020)

Transcriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective Antibiotics
por: Demirel, Isak, et al.
Publicado: (2017)

The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Escherichia coli Clone
por: Phan, Minh-Duy, et al.
Publicado: (2013)

Depletion of multidrug‐resistant uropathogenic Escherichia coli BC1 by ebselen and silver ion
por: Wang, Peng, et al.
Publicado: (2020)

Detection of biofilm among uropathogenic Escherichia coli and its correlation with antibiotic resistance pattern
por: Karigoudar, Rashmi M., et al.
Publicado: (2019)

Self-induced mechanical stress can trigger biofilm formation in uropathogenic Escherichia coli
por: Chu, Eric K., et al.
Publicado: (2018)

Biocide Exposure Induces Changes in Susceptibility, Pathogenicity, and Biofilm Formation in Uropathogenic Escherichia coli
por: Henly, E. L., et al.
Publicado: (2019)

Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli
por: Javed, Saima, et al.
Publicado: (2020)

Whole-genome sequence analysis of multidrug-resistant uropathogenic strains of Escherichia coli from Mexico
por: Paniagua-Contreras, GL, et al.
Publicado: (2019)

Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo′' to inhibition by the carbon monoxide-releasing molecule, CORM-3()(): N-acetylcysteine reduces CO-RM uptake and inhibition of respiration
por: Jesse, Helen E., et al.
Publicado: (2013)

Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli
por: Wojnicz, Dorota, et al.
Publicado: (2012)

Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment
por: Eberly, Allison R., et al.
Publicado: (2017)

Zinc oxide nanoparticle reduced biofilm formation and antigen 43 expressions in uropathogenic Escherichia coli
por: Shakerimoghaddam, Ali, et al.
Publicado: (2017)

Association between Biofilm-Production and Antibiotic Resistance in Uropathogenic Escherichia coli (UPEC): An In Vitro Study
por: Behzadi, Payam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k4e78asghkg44le479p2ojgskd